People · Operator
Named in public records as an officer, director or promoter · active 2009–2017 · Biotechnology, Other, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Palyon Medical Corp | — | Biotechnology | Series B | $45.0M | $952.5M | 2009 |
| IlluminOss Medical Inc | — | Other | Series B | $39.9M | $83.0M | 2014 |
| Euthymics Bioscience, Inc. | — | Biotechnology | Series B | $31.3M | $11.9M | 2017 |
| Insightra Medical, Inc. | — | Other Health Care | Series A | $20.0M | $100.9M | 2015 |
Daniel Omstead at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Daniel Omstead on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michael Liang | 2 | 9 |
| Amit Shah | 1 | 10 |
| Campbell Murray | 1 | 9 |
| Fouad Azzam | 1 | 8 |
| Rajeev Dadoo | 1 | 7 |
| Timothy J. Barberich | 1 | 7 |
| Timothy Barberich | 1 | 6 |
| Enrico Petrillo | 1 | 6 |
| Douglas A. Branch | 1 | 5 |
| Paul Weiss | 1 | 5 |
| Brigitte Smith | 1 | 5 |
| Lee Wrubel | 1 | 5 |
| Ron Hunt | 1 | 4 |
| Campbell A. Murray | 1 | 4 |
| Shane Johnson | 1 | 3 |
| Aidan King | 1 | 3 |
| David Present | 1 | 3 |
| Cherine Plumaker | 1 | 3 |
| Glen Kashuba | 1 | 3 |
| Harry T. Rein | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.